X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1918) 1918
Book Review (301) 301
Publication (239) 239
Newsletter (107) 107
Conference Proceeding (27) 27
Book Chapter (23) 23
Newspaper Article (17) 17
Magazine Article (3) 3
Dissertation (2) 2
Web Resource (2) 2
Trade Publication Article (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
posaconazole (1941) 1941
index medicus (1303) 1303
humans (1027) 1027
voriconazole (720) 720
antifungal agents - therapeutic use (517) 517
microbiology (511) 511
male (510) 510
itraconazole (503) 503
infectious diseases (459) 459
pharmacology & pharmacy (458) 458
female (425) 425
fluconazole (425) 425
antifungal agents (380) 380
middle aged (362) 362
antifungal agents - pharmacology (336) 336
amphotericin-b (332) 332
adult (328) 328
triazoles - therapeutic use (317) 317
mycoses (291) 291
amphotericin b (284) 284
mycology (279) 279
mucormycosis (274) 274
pharmacokinetics (250) 250
aspergillosis (249) 249
antifungal agents - administration & dosage (238) 238
prophylaxis (238) 238
aged (223) 223
health aspects (223) 223
triazoles - administration & dosage (213) 213
microbial sensitivity tests (211) 211
triazoles - pharmacology (211) 211
infections (201) 201
animals (198) 198
treatment outcome (197) 197
zygomycosis (191) 191
caspofungin (188) 188
therapy (183) 183
infection (182) 182
epidemiology (181) 181
research (177) 177
mycoses - drug therapy (175) 175
care and treatment (170) 170
triazoles (170) 170
transplantation (165) 165
invasive fungal-infections (164) 164
fungal-infections (162) 162
analysis (159) 159
fungal infections (157) 157
fungi (157) 157
adolescent (151) 151
chemotherapy (150) 150
antifungal agents - pharmacokinetics (146) 146
diagnosis (141) 141
young adult (140) 140
drug therapy (138) 138
triazoles - pharmacokinetics (134) 134
immunology (132) 132
risk factors (130) 130
mycoses - prevention & control (129) 129
susceptibility (128) 128
invasive aspergillosis (124) 124
retrospective studies (124) 124
immunocompromised host (123) 123
drug resistance, fungal (121) 121
neutropenia (121) 121
aspergillus (120) 120
leukemia (120) 120
safety (118) 118
dermatology (117) 117
hematology (117) 117
patients (117) 117
mice (116) 116
antifungal agents - adverse effects (114) 114
in-vitro (112) 112
cancer (110) 110
child (110) 110
drugs (108) 108
mortality (108) 108
internal medicine (105) 105
disease (103) 103
amphotericin b - therapeutic use (102) 102
antifungal prophylaxis (101) 101
triazoles - adverse effects (101) 101
micafungin (100) 100
aspergillosis - drug therapy (99) 99
dosage and administration (99) 99
drug interactions (99) 99
mycoses - microbiology (99) 99
in-vitro activities (97) 97
resistance (97) 97
therapeutic drug monitoring (97) 97
salvage therapy (95) 95
cell transplant recipients (94) 94
antiparasitic agents (92) 92
medical research (92) 92
pharmacology (92) 92
medicine & public health (91) 91
oncology (91) 91
management (89) 89
mucormycosis - drug therapy (89) 89
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1942) 1942
French (41) 41
Spanish (40) 40
German (37) 37
Turkish (6) 6
Polish (5) 5
Russian (5) 5
Korean (3) 3
Czech (2) 2
Chinese (1) 1
Hungarian (1) 1
Italian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 02/2004, Volume 38, Issue 3, pp. e15 - e20
A 41-year-old woman with no known immunosuppression experienced a 12-year period of a relapsing phaeohyphomycosis. Despite administration of multiple courses... 
posaconazole
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 04/2014, Volume 136, Issue 15, p. 5627
Journal Article
12/2010
Posaconazole is a novel second-generation Triazole oral antifungal agent. It is highly effective in the prophylaxis of invasive fungal infections in... 
invasive fungal infections | immunocompromised | candidiasis | Posaconazole
Web Resource
Pharmacotherapy, ISSN 0277-0008, 06/2007, Volume 27, Issue 6, pp. 825 - 834
Journal Article
Diagnostic Microbiology and Infectious Disease, ISSN 0732-8893, 2019
The present study was to determine the in vitro activity of posaconazole (POS)against 385 Candida and 268 Aspergillus clinical isolates from China. We found... 
Candida spp | Aspergillus spp | Posaconazole | Susceptibility
Journal Article
Clinical Microbiology and Infection, ISSN 1198-743X, 12/2011, Volume 17, Issue 12, pp. 1859 - 1867
Zygomycosis is an important emerging fungal infection, associated with high morbidity and mortality. The Working Group on Zygomycosis of the European... 
treatment | zygomycosis | Epidemiology | mucormycosis | Europe | Mucormycosis | Treatment | Zygomycosis | VORICONAZOLE | INFECTIOUS DISEASES | MICROBIOLOGY | INVASIVE FUNGAL-INFECTIONS | AMPHOTERICIN-B | IN-VITRO SUSCEPTIBILITIES | CELL TRANSPLANT RECIPIENTS | POSACONAZOLE PROPHYLAXIS | SURVEILLANCE NETWORK TRANSNET | BREAKTHROUGH ZYGOMYCOSIS | HEMATOLOGIC MALIGNANCIES | Age Distribution | Diabetes Complications | Prospective Studies | Fungi - classification | Humans | Middle Aged | Zygomycosis - mortality | Child, Preschool | Fungi - isolation & purification | Infant | Male | Young Adult | Hematopoietic Stem Cell Transplantation - adverse effects | Aged, 80 and over | Adult | Female | Hematologic Neoplasms - complications | Child | Risk Factors | Wounds and Injuries - complications | Europe - epidemiology | Zygomycosis - epidemiology | Adolescent | Survival Analysis | Sex Distribution | Aged | Antifungal Agents - administration & dosage | Amphotericin B | Analysis | Antiparasitic agents | Transplantation | Diabetes | Health aspects | Hematopoietic stem cells | Multivariate analysis | Medical research | Mortality | Cell culture | Diabetes mellitus | stem cell transplantation | Case reports | Malignancy | Regression analysis | Survival | Trauma | Morbidity | Soft tissues | Infection | Databases | Surgery | Caspofungin | Posaconazole | Age | Index Medicus
Journal Article
Mycoses, ISSN 0933-7407, 01/2011, Volume 54, pp. 12 - 16
Journal Article
Mycoses, ISSN 0933-7407, 01/2011, Volume 54, pp. 7 - 11
Journal Article
Archivos Argentinos de Pediatria, ISSN 0325-0075, 06/2018, Volume 116, Issue 3, pp. e451 - e454
Journal Article
International Journal of Infectious Diseases, ISSN 1201-9712, 06/2019, Volume 83, pp. 130 - 138
Novel formulations (gastro-resistant tablet and intravenous solution) of posaconazole (POS) have been approved in prophylaxis and therapy of invasive fungal... 
High-risk patient | Invasive fungal infection | Clinical effectiveness | Posaconazole serum level | Neutropenia | Medical research | Care and treatment | Hospitals | Analysis | Mortality | Mycoses | Medicine, Experimental | Posaconazole
Journal Article
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, ISSN 0253-2727, 02/2018, Volume 39, Issue 2, pp. 128 - 131
Journal Article
12/2008
A 53 year-old male diabetic presented with a month-old, painful ulcer with necrotic margins over the right thigh. Wound debridement was done twice and the... 
Mucormycosis | Apophysomyces elegans | Wound debridement | Amphotericin-B | Posaconazole
Web Resource
American Journal of Health-System Pharmacy, ISSN 1079-2082, 01/2014, Volume 71, Issue 1, p. 6
Journal Article
Journal Article
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, ISSN 0066-4804, 05/2019, Volume 63, Issue 5
Mucormycosis is an emerging disease with high mortality rates. Few antifungal drugs are active against Mucorales. Considering the low efficacy of monotherapy,... 
posaconazole | Mucorales | ASPERGILLUS-FUMIGATUS | THERAPY | zinc chelators | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | antifungal susceptibility testing
Journal Article
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, ISSN 0066-4804, 05/2019, Volume 63, Issue 5
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.